Analysts Set Anteris Technologies Global Corp. (NASDAQ:AVR) Price Target at $15.33

Shares of Anteris Technologies Global Corp. (NASDAQ:AVR) have received an average rating of “Moderate Buy” from the five analysts that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating and four have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $16.00.

A number of research firms have recently weighed in on AVR. Barclays upped their target price on shares of Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Wall Street Zen raised shares of Anteris Technologies Global from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Cantor Fitzgerald reissued an “overweight” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research report on Friday, March 27th. Lake Street Capital reissued a “buy” rating and set a $15.00 price objective on shares of Anteris Technologies Global in a research report on Friday, January 23rd. Finally, Wells Fargo & Company began coverage on shares of Anteris Technologies Global in a research report on Wednesday, March 11th. They set an “overweight” rating and a $16.00 price objective on the stock.

Anteris Technologies Global Trading Up 4.4%

Shares of NASDAQ AVR opened at $9.00 on Friday. Anteris Technologies Global has a 12 month low of $2.85 and a 12 month high of $9.28. The firm has a market capitalization of $876.06 million, a PE ratio of -4.04 and a beta of 1.32. The firm has a fifty day simple moving average of $6.11 and a two-hundred day simple moving average of $5.47.

Anteris Technologies Global (NASDAQ:AVR) last released its earnings results on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The business had revenue of $0.49 million during the quarter, compared to analysts’ expectations of $0.77 million. Anteris Technologies Global had a negative return on equity of 124.76% and a negative net margin of 5,148.78%.During the same period in the prior year, the company earned ($0.61) earnings per share. On average, sell-side analysts predict that Anteris Technologies Global will post -1.14 earnings per share for the current year.

Institutional Trading of Anteris Technologies Global

Several institutional investors have recently bought and sold shares of AVR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Anteris Technologies Global during the 1st quarter valued at about $32,000. Geode Capital Management LLC boosted its holdings in shares of Anteris Technologies Global by 154.3% during the 2nd quarter. Geode Capital Management LLC now owns 420,427 shares of the company’s stock valued at $1,593,000 after acquiring an additional 255,088 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Anteris Technologies Global by 9,958.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock valued at $4,049,000 after acquiring an additional 1,057,707 shares during the last quarter. Nantahala Capital Management LLC boosted its holdings in shares of Anteris Technologies Global by 1.8% during the 2nd quarter. Nantahala Capital Management LLC now owns 1,693,666 shares of the company’s stock valued at $6,419,000 after acquiring an additional 30,000 shares during the last quarter. Finally, Vanguard Group Inc. boosted its holdings in shares of Anteris Technologies Global by 85.1% during the 3rd quarter. Vanguard Group Inc. now owns 745,560 shares of the company’s stock valued at $3,355,000 after acquiring an additional 342,711 shares during the last quarter.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.